Last 12 months
Inside the activity.
16 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 12 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 24, 2018 Filed Mar 27, 2018 16:59 UTC |
LeBar JamesDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000336 · zomedica_form4jan242018.xml · derivative · entry 2 LeBar James · CIK 0001721721 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, without par value · 100,000 shares Expires 2018-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| January 24, 2018 Filed Mar 27, 2018 16:59 UTC |
LeBar JamesDirector
|
Exercise / conversionCommon Shares, without par value | 100,000 | $0.20 | $20,000.00 |
DisclosureSEC source: 0000905718-18-000336 · zomedica_form4jan242018.xml · nonDerivative · entry 1 LeBar James · CIK 0001721721 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2018 Filed Jan 8, 2018 17:58 UTC |
Shameze RampertabDirector · Chief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 124,000 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000038 · zomedica_fm4jan82018.xml · derivative · entry 5 Shameze Rampertab · CIK 0001721810 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,000 Underlying: Common Shares, without par value · 124,000 shares Expires 2018-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| January 08, 2018 Filed Jan 8, 2018 17:58 UTC |
Shameze RampertabDirector · Chief Financial Officer
|
Exercise / conversionCommon Shares, without par value | 124,000 | $0.20 | $24,800.00 |
DisclosureSEC source: 0000905718-18-000038 · zomedica_fm4jan82018.xml · nonDerivative · entry 1 Shameze Rampertab · CIK 0001721810 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 19, 2017 Filed Dec 19, 2017 19:36 UTC |
Solensky Gerald JRDirector · President and CEO · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 750,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0000905718-17-001034 · zomed_fm4solen12192017.xml · derivative · entry 2 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Shares, without par value · 750,000 shares Expires 2018-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| December 19, 2017 Filed Dec 19, 2017 19:36 UTC |
Solensky Gerald JRDirector · President and CEO · 10% owner
|
Exercise / conversionCommon Shares, without par value | 750,000 | $1.20 | $900,000.00 |
DisclosureSEC source: 0000905718-17-001034 · zomed_fm4solen12192017.xml · nonDerivative · entry 1 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,951,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.